Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: Federal Circuit
U.S. Court of Appeals Stays Decision to Bar Stem Cell Funding
A three judge panel of the Court of Appeals for the District of Columbia stayed the recent district court ruling which voided President Obama’s executive order permitting Federal funding for research on an expanded number of embryogenic stem cell lines … Continue reading
O’Malley Nomination To Fed. Cir. Moves Forward
On September 23rd, the Senate Judiciary Committee approved the nomination of Judge Kathleen O’Malley (N.D. Ohio) to fill a vacancy on the Federal Circuit. Judge O’Malley has handled significant IP litigation and is married to veteran Covington patent litigator George Pappas. Like … Continue reading
Stem Cell Funding Ban Stayed by D.C. Cir.
The United States Court of Appeals for the District of Columbia Circuit stayed the order of the D.C. District Court that had nullified President Obama’s executive order restoring Federal funding for research on embryonic stem cells (ESCs) as conflicting with … Continue reading
Posted in Stem Cells/Cloning
Tagged biotechnology law, biotechnology news, Federal Circuit, stem cells, Warren Woessner
Leave a comment
Court Blocks Obama’s Stem Cell Order
In December of 2009, I argued that President Obama’s Executive Order 13505, that lifted President Bush’s 2001 Order banning the use of federal funds for embryonic stem cell (ESC) research, should be a Top Biotech Story of 2009. The Bush … Continue reading